A short-term cognitive group treatment program gives substantial weight reduction up to 18 months from the end of treatment. A randomized controlled trial

被引:0
|
作者
Stahre L. [1 ,2 ]
Hällström T. [1 ]
机构
[1] Neurotec Department, Karolinska Institutet, Huddinge University Hospital, Stockholm
[2] SE-633 47 Eskilstuna
关键词
Binge eating disorder; Cognitive treatment; Efficacy; Helplessness; Obesity; Psycho-education; Randomized controlled trial; Stress;
D O I
10.1007/BF03353419
中图分类号
学科分类号
摘要
Objective: To describe and evaluate long-term efficacy (18 months from the end of treatment) of a new cognitive short-term weight reducing treatment program for obese patients. Subjects: One hundred and five obese [Body Mass Index (BMI) ≥30] patients participated in the study. Of these, 62 took part in the treatment program and 43 served as controls. Method: From an obesity unit's waiting list, the patients were randomly assigned to either a treatment group or remained in the waiting list to serve as a control group. The treatment group participated in a 10-week (30 hours) cognitive group treatment program. All participants were weighed at the outset of the study, directly after treatment and at a 6-, 12- and 18-month posttreatment follow-up without any booster treatment after the 10-week program. Results: Fiftyseven (92%) patients completed treatment. For the 34 (60%) patients who participated in the study 18 months after treatment was terminated, the mean weight loss at treatment's end was 8.5 kg (SD=16.1). Eighteen months later their mean weight loss was 10.4 kg (SD=10.8). The control patients (n=31, 72%) that participated in the study during the same period increased in weight by 2.3 kg (SD=7.0). The weight difference between the treatment and control group at the 18-month follow-up was highly significant (p<0.001). Conclusion: The cognitive group treatment program was highly acceptable among the participants and was completed by nearly all the patients. The 10-week treatment program resulted in satisfactory weight loss. The weight difference between the treatment group and controls was nearly the same at 18 monthts after end of treatment as at six months. The study, therefore, does not provide support for the contention that a lengthy therapy for obesity is necessary if treatment results are lasting. ©2005, Editrice Kurtis.
引用
收藏
页码:51 / 58
页数:7
相关论文
共 50 条
  • [1] A randomized controlled trial of two weight-reducing short-term group treatment programs for obesity with an 18—month follow—up
    Lisbeth Stahre
    Berit Tärnell
    Carl-Erik Håkanson
    Tore Hällström
    International Journal of Behavioral Medicine, 2007, 14 : 48 - 55
  • [2] A randomized controlled trial of two weight-reducing short-term group treatment programs for obesity with an 18-month follow-up
    Stahre, Lisbeth
    Tarnell, Berit
    Hakanson, Carl-Erik
    Hallstrom, Tore
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2007, 14 (01) : 48 - 55
  • [3] Effects of short-term treatment with atorvastatin in smokers with asthma - a randomized controlled trial
    Georgina Braganza
    Rekha Chaudhuri
    Charles McSharry
    Christopher J Weir
    Iona Donnelly
    Lisa Jolly
    Jane Lafferty
    Suzanne M Lloyd
    Mark Spears
    Frances Mair
    Neil C Thomson
    BMC Pulmonary Medicine, 11
  • [4] Effects of short-term treatment with atorvastatin in smokers with asthma - a randomized controlled trial
    Braganza, Georgina
    Chaudhuri, Rekha
    McSharry, Charles
    Weir, Christopher J.
    Donnelly, Iona
    Jolly, Lisa
    Lafferty, Jane
    Lloyd, Suzanne M.
    Spears, Mark
    Mair, Frances
    Thomson, Neil C.
    BMC PULMONARY MEDICINE, 2011, 11
  • [5] A CONTROLLED TRIAL OF SHORT-TERM GROUP TREATMENT FOR BORDERLINE PERSONALITY-DISORDER
    MUNROEBLUM, H
    MARZIALI, E
    JOURNAL OF PERSONALITY DISORDERS, 1995, 9 (03) : 190 - 198
  • [6] No Reduction in Circulating Preosteoclasts 18 Months after Treatment with Zoledronate: Analysis from a Randomized Placebo Controlled Trial
    Dalbeth, Nicola
    Pool, Bregina
    Stewart, Angela
    Horne, Anne
    House, Meaghan E.
    Cornish, Jillian
    Reid, Ian R.
    CALCIFIED TISSUE INTERNATIONAL, 2013, 92 (01) : 1 - 5
  • [7] No Reduction in Circulating Preosteoclasts 18 Months after Treatment with Zoledronate: Analysis from a Randomized Placebo Controlled Trial
    Nicola Dalbeth
    Bregina Pool
    Angela Stewart
    Anne Horne
    Meaghan E. House
    Jillian Cornish
    Ian R. Reid
    Calcified Tissue International, 2013, 92 : 1 - 5
  • [8] Short-term effects of enhanced treatment for depression in primary care: results from a randomized controlled trial
    Smit, A
    Kluiter, H
    Conradi, HJ
    van der Meer, K
    Tiemens, BG
    Jenner, JA
    van Os, TWDP
    Ormel, J
    PSYCHOLOGICAL MEDICINE, 2006, 36 (01) : 15 - 26
  • [9] Short-Term Exercise Training for Treatment of Generalized Anxiety Disorder: A Randomized Controlled Trial
    Herring, Matthew P.
    Jacob, Marni L.
    Suveg, Cynthia
    Dishman, Rodney K.
    O'Connor, Patrick J.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2011, 43 (05): : 21 - 22
  • [10] Short-term treatment of a resilient appliance in TMD pain patients: a randomized controlled trial
    Nilsson, H.
    Limchaichana, N.
    Nilner, M.
    Ekberg, E. C.
    JOURNAL OF ORAL REHABILITATION, 2009, 36 (08) : 547 - 555